Home
About
Overview
Sharing Data
ORCID
Help
History (70)
Zika Virus
NFI transcription factors provide chromatin access to maintain stem cell identity while preventing unintended lineage fate choices.
Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.
Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
See All 70 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. Eur J Cancer. 2019 10; 120:132-139.
View in:
PubMed
subject areas
Aged
Alanine
Antineoplastic Agents
Biomarkers, Tumor
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasms
Prognosis
Survival Rate
Triazines
Withholding Treatment
authors with profiles
Mark Ratain
Bruce E. Brockstein